Skip to main content

Table 4 Cost-minimization analyses

From: Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan

Regimen Comparison of cost Comparison of effectiveness Cost-minimization analyses
CapeOX vs. mFOLFOX6 Comparable Comparable Comparable
UFT/LV vs. S-1 Higher in UFT/LV than S-1 Comparable S-1 superior to UFT/LV
UFT/LV vs. capecitabine Higher in UFT/LV than capecitabine Comparable Capecitabine superior to UFT/LV